Pergolide, terguride and N,N′-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery

被引:13
作者
Kren, V [1 ]
Eich, E
Pertz, HH
机构
[1] Acad Sci Czech Republ, Inst Microbiol, Lab Biotransformat, Videnska 1083, CZ-14220 Prague 4, Czech Republic
[2] Free Univ Berlin, Inst Pharm, D-1000 Berlin, Germany
关键词
pergolide; terguride; oligomers of pergolide and terguride; 5-HT2A receptors; contraction; rat tail artery;
D O I
10.33549/physiolres.930402
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pergolide, terguride and N,N'-spacer-linked oligomers of both have been tested for their ability to interact with 5-hydroxytryptamine(HT)(2A) receptors of rat tail artery. Pergolide was a potent partial agonist (pEC(50) 7.5, E-max 55%) and antagonized 5-HT-induced contractions (pK(p) 7.2). Pergolide dimer 3 with a p-xylene spacer between the indole nitrogens (N-1) displayed somewhat lower agonist potency than pergolide (pEC(50) 7.0, E-max 55%, pK(p) 6.6). The contractile responses to pergolide and dimer 3 were antagonized by the 5-HT2A receptor antagonist ketanserin (pA(2) 9.4, 9.1). In contrast to pergolide dimer 3, pergolide dimers 5 and 9 with an alkyl and an aralkyl spacer between the piperidine nitrogens (N-6) lacked agonism and displayed low affinity at 5-HT2A receptors (pA(2) < 5.5). Terguride behaved as an insurmountable antagonist of 5-HT (pA(2) 8.4). Oligomers of terguride showed 5 to 50-fold lower affinity. It is concluded that pergolide and terguride show a high affinity for 5-HT2A receptors, but dimerization (oligomerization) of both drugs fails to increase affinity.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 15 条
[1]   PERGOLIDE - A DOPAMINE AGONIST AT BOTH D1-RECEPTORS AND D2-RECEPTORS [J].
FULLER, RW ;
CLEMENS, JA .
LIFE SCIENCES, 1991, 49 (13) :925-930
[2]  
Furchgott R.F., 1972, Catecholamines, P283
[3]  
Hagen Jayne D., 1994, Biological Signals, V3, P223
[4]   Serotonin dimers: Application of the bivalent ligand approach to the design of new potent and selective 5-HT1B/1D agonists [J].
Halazy, S ;
Perez, M ;
Fourrier, C ;
Pallard, I ;
Pauwels, PJ ;
Palmier, C ;
John, GW ;
Valentin, JP ;
Bonnafous, R ;
Martinez, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4920-4927
[5]   Clustered ergot alkaloids modulate cell-mediated cytotoxicity [J].
Kren, V ;
Fiserová, A ;
Weignerová, L ;
Stibor, I ;
Halada, P ;
Prikrylová, V ;
Sedmera, P ;
Pospísil, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (02) :415-424
[6]   Semisynthetic dimers of antiparkinsonic ergot alkaloids [J].
Kren, V ;
Weignerová, L ;
Kuzma, M ;
Jegorov, A ;
Sedmera, P .
HETEROCYCLES, 2001, 55 (06) :1045-1056
[7]  
MARANO M, 1976, J PHARMACOL EXP THER, V198, P518
[8]   Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes [J].
Perez, M ;
Jorand-Lebrun, C ;
Pauwels, PJ ;
Pallard, I ;
Halazy, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (11) :1407-1412
[9]  
Pertz H. E. I. N. Z., 1999, Ergot: The genus Claviceps, P411
[10]   Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors:: Pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity [J].
Pertz, HH ;
Milhahn, HC ;
Eich, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (04) :659-668